Remove 2012 Remove Protein Expression Remove RNA
article thumbnail

Marvin Caruthers receives inaugural Merkin Prize in ceremony at the Broad Institute for DNA synthesis technology

Broad Institute

Today, scientists use such reactions to produce the customizable DNA and RNA molecules that enable genetic sequencing, drug and vaccine development, pathogen tests, cancer diagnostics, and more. Wang concluded her presentation by expressing gratitude to Merkin. I’m really thankful for the support of the Merkin Fellowship,” she said. “It

DNA 52
article thumbnail

Clinical Catch-Up: January 4-8 | BioSpace

The Pharma Data

Precigen received the okay from the FDA to initiate a Phase I trial of PRGN-2012 in recurrent respiratory papillomatosis (RRP). PRGN-2012 is a first-in-class, off-the-shelf AdenoVerse immunotherapy using the company’s gorilla adenovector technology, part of its proprietary AdenoVerse platform.